Josias Pontes is CHIEF FINANCIAL OFFICER of Sigilon Therapeutics, Inc.. Currently has a direct ownership of 0 shares of SGTX, which is worth approximately $0. The most recent transaction as insider was on Aug 11, 2023, when has been sold 3,504 shares (Common Stock) at a price of $0.0 per share, resulting in proceeds of $0. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 0
0% 3M change
0% 12M change
Total Value Held $0

Josias Pontes Transaction History

Date Transaction Value Shares Traded Shares Held Form
Aug 11 2023
SELL
Sale (or disposition) back to the issuer
-
3,504 Reduced 100.0%
0 Common Stock
Jul 21 2023
BUY
Exercise of conversion of derivative security
$27,782 $19.24 p/Share
1,444 Added 30.74%
3,254 Common Stock
Sep 30 2021
BUY
Grant, award, or other acquisition
-
11,500 Added 46.3%
13,339 Common Stock
JP

Josias Pontes

CHIEF FINANCIAL OFFICER
Cambridge, MA

Track Institutional and Insider Activities on SGTX

Follow Sigilon Therapeutics, Inc. and customize your updates to receive the information that matters most to you.

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells SGTX shares.

Notify only if

Insider Trading

Get notified when an Sigilon Therapeutics, Inc. insider buys or sells SGTX shares.

Notify only if

News

Receive news related to Sigilon Therapeutics, Inc.

Track Activities on SGTX